According to an announcement made by CSPC PHARMA (01093) on October 16, 2025, the trustee has acquired a total of 4.496 million shares of the company on the market, in accordance with the terms and conditions of its restricted stock award scheme. These shares are held in trust for the benefit of selected participants.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.